According to our new research study on “Asia Pacific Point-of-Care Molecular Diagnostics Market to 2028 – Regional Analysis and Forecast – by Product & Services, Technology, Application, and End User,” the market is projected to reach US$ 1,251.67 million by 2028 from US$ 499.19 million in 2021; it is expected to grow at a CAGR of 14.0% from 2022 to 2028.

The growth of the market is primarily attributed to the growing demand for specific viral detection methods that consume less time for timely infection control and rising incidence of infectious diseases. Moreover, rising R&D and innovation in Asia Pacific point-of-care molecular diagnostics are expected to foster the market growth during the forecast period. However, the pricing pressures owing to reimbursement cuts hinder the market growth. The COVID-19 pandemic has had a significant positive impact on the point-of-care molecular diagnostic market. Amid the pandemic, the increased demand for diagnostic kits for the rapid detection of COVID-19 boosted the adoption of point-of-care testing across the world. The rising number of COVID-19 cases and growing pressure on various governments across the world to improve patient management have boosted the demand for rapid antigen testing kits that can be effectively used in point-of-care settings.
Based on product & services, the Asia Pacific point-of-care molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays & kits segment leads the market and is expected to register the highest CAGR during the forecast period. Based on technology, the Asia Pacific point-of-care molecular diagnostics market is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. The PCR segment leads the market, whereas the isothermal nucleic acid amplification technology (INAAT) segment is expected to register the highest CAGR during the forecast period. By application, the Asia Pacific point-of-care molecular diagnostics market is segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. The infectious diseases segment holds the largest share of the Asia Pacific point-of-care molecular diagnostics market. However, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period. By end user, the Asia Pacific point-of-care molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutes, and others. The diagnostic laboratories segment leads the market and is estimated to register the highest CAGR in the market during the forecast period.

Point-of-care (POC) molecular tests are accurate and scalable that increase the scope for the diagnosis of diseases, which can be done in the community and outside the laboratory setting. Compared with laboratory testing, point-of-care molecular diagnostics provides various advantages such as fewer clinic visits, shorter hospital stays, better drug therapy optimization, and less inappropriate drug use. The healthcare sector is undergoing huge transformation due to the emergence of new and effective technologies across the sector. Thus, the growing demand for effective diagnostics that consumes less time than laboratory testing drives the demand for POC molecular assays and kits propelling the growth of Asia Pacific point-of-care molecular diagnostics market over the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and International Agency for Research on Cancer are a few of the primary and secondary sources referred to while preparing the report on the Asia Pacific point-of-care molecular diagnostics market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 Asia Pacific Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 Asia Pacific Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 Asia Pacific Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 Asia Pacific Point-of-Care Molecular Diagnostics Market– By Geography
2. Asia Pacific Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– Asia Pacific Analysis
6.1 Asia Pacific Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & Services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & Services 2021 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 Asia Pacific: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.4 Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.5 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.6 Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 China: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.1.5 China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Japan: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.2.5 Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 India: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.3.5 India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.4 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.4.1 Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.4.2 Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.4.3 Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.4.4 Australia: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.4.5 Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.5 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.5.1 South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.5.2 South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.5.3 South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.5.4 South Korea: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.5.5 South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.6 Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.6.1 Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.6.2 Thailand: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.6.3 Thailand Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.6.4 Thailand: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.6.5 Thailand Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.7 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.7.1 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.7.2 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
11.1.7.7.3 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.7.4 Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application, 2019–2028 (USD Million)
11.1.7.7.5 Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms

LIST OF TABLES
Table 1. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 2. Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. China: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 6. China Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. China: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. China Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Japan: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Japan Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. India: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 14. India Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. India: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. India Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Australia: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 18. Australia Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 19. Australia: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Australia Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 23. South Korea: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. South Korea Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Thailand: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 26. Thailand Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 27. Thailand: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 28. Thailand Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 33. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 34. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 35. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Asia Pacific Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & Services in Asia Pacific Point-of-Care Molecular Diagnostics Market
Figure 4. India to Show Significant Growth During Forecast Period
Figure 5. Asia Pacific Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. Asia Pacific Point-of-Care Molecular Diagnostics Market- Leading Country Markets (US$ Million)
Figure 7. Asia Pacific PEST Analysis
Figure 8. Asia Pacific Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028
Figure 9. Point-of-Care Molecular Diagnostics Market, by Product & Services 2021 & 2028 (%)
Figure 10. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Point-of-Care Molecular Diagnostics Market, by Technology 2021 & 2028 (%)
Figure 14. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Point-of-Care Molecular Diagnostics Market, by Application 2021 & 2028 (%)
Figure 18. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Point-of-Care Molecular Diagnostics Market, by End User 2021 & 2028 (%)
Figure 25. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Asia Pacific: Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 31. Asia Pacific: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 32. China: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Japan: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. India: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Australia: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. South Korea: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Thailand: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Rest of Asia Pacific: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Asia Pacific
Figure 40. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific point-of-care molecular diagnostics market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific point-of-care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Asia Pacific POC Molecular Diagnostics Market
• bioMérieux SA
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Enzo Biochem, Inc.
• Abbott
• binx health, Inc.
• Meridian BioScience, Inc.
• Biocartis
• Quidel Corporation
• Bio-Rad Laboratories, Inc.